These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2501090)

  • 1. Transdermal nitroglycerin in angina pectoris.
    Abrams J
    Eur Heart J; 1989 May; 10 Suppl A():11-9. PubMed ID: 2501090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
    Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
    Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.
    Todd PA; Goa KL; Langtry HD
    Drugs; 1990 Dec; 40(6):880-902. PubMed ID: 2127741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
    Freedman SB; Daxini BV; Noyce D; Kelly DT
    J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
    Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
    J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ointments and transdermal nitroglycerin patches for stable angina pectoris.
    Thadani U; Lipicky RJ
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):625-33. PubMed ID: 7848897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance, rebound, and time-zero effect of nitrate therapy.
    Frishman WH
    Am J Cardiol; 1992 Nov; 70(17):43G-47G; discussion 47G-48G. PubMed ID: 1449099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance development during transdermal administration of nitroglycerin in angina pectoris.
    Rehnqvist N
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 6():113-5. PubMed ID: 3098045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin.
    Nabel EG; Barry J; Rocco MB; Mead K; Selwyn AP
    Am J Cardiol; 1989 Mar; 63(11):663-9. PubMed ID: 2493732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina.
    Gumbrielle T; Freedman SB; Fogarty L; Ogasawara S; Sobb P; Kelly DT
    Eur Heart J; 1992 May; 13(5):671-8. PubMed ID: 1618212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of transdermal nitroglycerin efficacy with dosage in different subsets of patients.
    Rezaković DE
    Am J Cardiol; 1988 Mar; 61(9):59E-69E. PubMed ID: 3126637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule.
    Ferratini M; Pirelli S; Merlini P; Silva P; Pollavini G
    Eur Heart J; 1989 Nov; 10(11):998-1002. PubMed ID: 2512162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic attenuation and the nitrate-free interval: alternative dosing strategies for transdermal nitroglycerin.
    Flaherty JT
    Am J Cardiol; 1985 Dec; 56(17):32I-37I. PubMed ID: 3000161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
    DeMots H; Glasser SP
    J Am Coll Cardiol; 1989 Mar; 13(4):786-95. PubMed ID: 2494240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
    Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
    Parker JO
    J Am Coll Cardiol; 1989 Mar; 13(4):794-5. PubMed ID: 2494241
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.
    Schaer DH; Buff LA; Katz RJ
    Am J Cardiol; 1988 Jan; 61(1):46-50. PubMed ID: 3122549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.
    Luke R; Sharpe N; Coxon R
    J Am Coll Cardiol; 1987 Sep; 10(3):642-6. PubMed ID: 3114351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.